Successful Treatment of Severe Post-partum Bleeding after Caesarean Section Using Recombinant Activated Factor VII

Authors: Z. Holub 1;  J. Feyereisl 2;  L. Kabelík 3;  T. Rittstein 1
Authors‘ workplace: Gynekologicko-porodnické oddělení, Nemocnice Kladno, primář doc. MUDr. Z. Holub, CSc. 1;  Gynekologicko-porodnická klinika, Ústav pro péči o matku a dítě, Praha, ředitel doc. MUDr. J. Feyereisl, CSc. 2;  Anesteziologicko-resuscitační oddělení, Nemocnice Kladno, primář MUDr. K. Kodras 3
Published in: Čes. Gynek.2005, 70, č. 2 s. 144-148
Category: Original Article


To present a case report of severe post-partum bleeding after caesarean section and successful using recombinant factor VIIa.

Department Obstetrics and Gynecology, Regional Hospital, Kladno, Czech Republic.

Case Report:
A 28-year old nullipara presented with major post-partum bleeding after caesarean section due to uterine atony. The patient developed hemorrhagic shock, associated with disseminated intravascular coagulation (DIC). Treatment with uterotonics drug, prostaglandins, hysterectomy and packing of the pelvis failed to control diffuse pelvic and vaginal bleeding. Recombinant factor VIIa (2.4 mg intravenous injection) was given as a final attempt to control the bleeding before relaparotomy and ligation hypogastric artery. The response to treatment was rapid, with control of the bleeding and resolution of the coagulopathy.

This case suggests a potential role of recombination factor VIIa in the treatment of severe post-partum bleeding associated with DIC.

Key words:
recombinant activated factor VII, disseminated intravascular coagulation, post-partum bleeding

Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine

Article was published in

Czech Gynaecology

Issue 2

2005 Issue 2

Most read in this issue

This topic is also in:

Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account